Highlight | Cellular mechanisms | Genetic diseases
Some diseases cause the toxic accumulation of copper in the liver, and the present chelators have many side effects. The results obtained by researchers at the Chemistry and Biology of Metals laboratory in collaboration with teams from INAC, UJF and Orsay allow to consider that new chelators act as potential drugs against liver intoxications by copper and thus contribute to a new therapeutic approach.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.